SEC Tracker
Get the app

Bioforce Nanosciences Holdings BFNH

Bioforce Nanosciences Holdings Q3 FY24: net loss $122K; diluted EPS $0.00

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Bioforce Nanosciences Holdings reported for Q3 FY24, the quarter ended Sep 30, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Net income−$122KAgainst −$114K in Q3 FY2310-Q income statement, on EDGAR
  2. Diluted EPS$0.00Against $0.00 in Q3 FY2310-Q income statement, on EDGAR
  3. Cash and cash equivalents$2K+138% from $686 in Q3 FY2310-Q balance sheet, on EDGAR
  4. Cash from operations−$15KAgainst −$8K in Q3 FY2310-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Bioforce Nanosciences Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3826 and related industry codes: the same peer list as the financial tables.

  1. Scientific Industries SCND public float $4M, Jun 30, 2025
  2. Lifeloc Technologies LCTC public float $2M, Jun 30, 2025
  3. US Nuclear UCLE public float $1M, Jun 30, 2025
  4. ASTROTECH ASTC public float $5M, Dec 31, 2025
  5. Electro Sensors ELSE public float $6M, Jun 30, 2025